How do I export medical devices?

Major Export Markets and Country-Specific Regulatory Frameworks

The US FDA market is the world's largest medical device market, with FDA authorization through 510(k) notification or PMA (premarket approval) being a prerequisite for market entry. The 510(k) notification proves substantial equivalence to an existing cleared product (Predicate Device), with an average processing period of 6–12 months and costs in the range of $5,000–$100,000. The EU market has significantly strengthened regulatory levels with the full implementation of MDR (Medical Device Regulation, EU 2017/745) in 2021, requiring examination by an EU-authorized certification body (Notified Body) to obtain CE marking. China NMPA (National Medical Products Administration) registration requires mandatory designation of a local company representative (Legal Representative) for Class II and above products, with an average of 1–3 years to complete registration. Japan PMDA (Pharmaceuticals and Medical Devices Agency) authorization is known to be demanding, but Korean MFDS-approved products can receive simplified procedures for some classes, making strategic approach worthwhile.

Core Certification Acquisition Strategy and Procedures

The first step in medical device exports is completing medical device authorization/registration from the Korean Ministry of Food and Drug Safety (MFDS), which is one of the basic documents required by most destination countries. ISO 13485 (Medical Device Quality Management System) certification is a common foundational requirement for global market entry, linked to CE marking, FDA QSR regulation compliance, PMDA, and other multi-country authorization requirements. Certification priorities should be determined considering target markets and product class; FDA 510(k) has a high cost-to-efficiency ratio, and CE marking provides access to the entire EU market, so pursuing both certifications simultaneously is generally the strategy. IVDR (In-vitro Diagnostic Device Regulation) is being phased in from 2022, and many existing IVD products require CE marking renewal, making validity period management important. Using a Regulatory Consultant to quickly understand country-specific requirements and reduce documentation errors is possible, and part of consulting costs can be subsidized through KHIDI's overseas medical device authorization support project.

Export Procedures, HS Codes, and Customs Clearance

Medical devices primarily fall under HS Code Chapter 90 (optical, photographic, medical, and surgical instruments), further subdivided into diagnostic equipment (9018), dental devices (9021), orthopedic devices (9021), and medical furniture (9402). Accurate HS code classification determines the importing country's tariff rates and whether medical device regulations apply, so advance review with a specialized customs broker is essential. For medical device exports, the MFDS Certificate of Free Sale issued by the Korean Ministry of Food and Drug Safety is the core export document, and additional documents such as GMP certificates, free sale certificates, and technical documents may be required depending on the importing country. IVD reagents requiring cold/frozen storage must apply cold chain logistics, and use of data loggers to prevent temperature deviations during international transport is recommended. For sterile medical devices, packaging validation maintaining aseptic conditions during the period from EO (ethylene oxide) or radiation sterilization treatment to customs clearance must be completed before shipment.

Overseas Buyer Sourcing and Distribution Channel Development

The most effective method for medical device buyer sourcing is participation in major medical device trade shows such as MEDICA (Dusseldorf, Germany), Arab Health (Dubai, UAE), and Hospitalar (São Paulo, Brazil), which are the best platforms for short-term contact with global buyers. When selecting a local medical device distribution agent (Distributor), local regulatory authorization acquisition experience, medical institution network, technical support capability, and financial soundness must be reviewed, and a performance-linked contract structure is more advantageous for risk management than exclusive contracts. Utilizing KHIDI's overseas buyer invitation consultation sessions and KOTRA's medical device specialty trade mission programs allows securing contact opportunities with verified buyers at low cost. Digital channel utilization is also becoming important; registering products on global medical device online platforms such as Medline Industries and Henry Schein, or directly approaching hospital medical equipment procurement officers through LinkedIn, is also effective. Operating product demonstration (Demo) programs targeting local hospitals and clinics is effective for trust building given medical device characteristics, and collaboration with KOLs (Key Opinion Leaders — doctors and professors) to enhance clinical credibility is important.

Pricing Strategy and Rebate Regulation Compliance

Medical device export prices must be calculated reflecting product class, certification costs, local import duties, distribution margins (typically 20–40%), and local after-sales service costs, with market-differentiated pricing strategies generally applied. Payment terms require a phased approach of T/T prepayment or L/C as a principle for initial transactions with new buyers, with 60–90 day payment terms (O/A) provided to long-term trading partners. The medical device industry applies strict rebate (providing money to healthcare providers) regulations, and compliance with the US Anti-Kickback Statute and each EU country's health codes is the core of legal risk prevention. When setting prices, local government health insurance reimbursement status must be considered; reimbursed products have regulated prices but can secure stable sales volumes. Utilizing Korea Trade Insurance Corporation's (KSURE) medium-to-long-term export insurance can hedge the risk of uncollectable payments for large-scale supply contracts with major hospitals or government institutions.

Global Marketing and Clinical Data Utilization

In medical device export marketing, clinical data and Evidence-Based Medicine (EBM) materials are the most powerful marketing tools; papers published in peer-reviewed journals or clinical trial results must be prepared in English and provided to buyers. Enhancing product awareness through technical articles or advertising in global medical specialist media (Medscape, Medical Device Network, MedTech Intelligence, etc.) is effective. Joint clinical research with local KOL physicians, academic presentations, and symposium hosting are recognized as the most credible marketing methods for medical devices. Digital marketing strategies including English product website SEO optimization, YouTube product demonstration videos, and webinar operations are effective, and the importance of digital channels has further increased after COVID. Participating in the 'Korea Medical Device' joint branding campaign operated by KHIDI to improve the global recognition of Korean medical devices can maximize marketing effects.

Logistics, Packaging, and After-Sales Service System

Medical device packaging requires validity verification (Packaging Validation) per international standards such as ISO 11607 (sterile packaging standards) and ASTM, and must guarantee protection from damage, contamination, and maintenance of sterile conditions during transport. For temperature-sensitive products (IVD reagents, some implants), cold chain management using WHO PQS-certified refrigerated containers and data loggers is mandatorily applied. Building a global after-sales service (AS) system for medical devices is equally important as sales; securing local technical support partners, maintaining spare parts inventory, and operating remote diagnostics systems are key to long-term customer retention. UDI (Unique Device Identification) systems are mandatory by US FDA and EU MDR, and affixing UDI labels to products and completing database registration must be done before export. Clearly establishing return and inventory management policies and specifying return handling procedures, cost-bearing parties, and disposal methods in distribution partner contracts is essential for dispute prevention.

Key Trade Shows and Global Medical Device Networking

MEDICA (Dusseldorf, Germany, November annually) is the world's largest medical device trade show, with 5,000+ companies and 80,000+ professionals from over 70 countries participating, the optimal platform for sourcing global distribution partners. Arab Health (Dubai, UAE, January annually) is the largest medical device trade show in the Middle East and Africa, an essential networking event for companies targeting market entry in this region. KHIDI's overseas medical device trade show joint participation project allows 30–50% cost savings compared to individual participation, along with KOTRA trade center local support, which is particularly advantageous for initial export companies. Proactively grasping the latest regulatory trends and building regulatory expert networks through participation in the International Medical Device Regulators Forum (IMDRF) and APAC regulatory harmonization working groups is important in the long term. Utilizing collective capabilities such as information sharing, joint trade show participation, and policy opinion submission through active membership in the Korea Medical Device Industry Association (KMDIA) and Korea Medical Device Manufacturers and Distributors Cooperative (KMFDC).

Buyer Types

Essential Certifications

Key Trade Shows

Frequently Asked Questions